H
Harpal
About Harpal
Data last updated:
Harpal is a Director at Physa Pharmaceuticals Private Limited (since 2022). The companies operate in Chemicals and Information Technology. Physa Pharmaceuticals Private Limited reported revenue of ₹70.7 Lakh (FY 2025). Earlier, Harpal was a Director at Webgallant Services Private Limited (2013–2014).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Physa Pharmaceuticals Private Limited U24230UP2019PTC122896 | Director | 24 Jun 2022 | 2019 | ₹70.7 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Webgallant Services Private Limited U72300DL2013PTC260944 | Director | 26 Nov 2013 | 2013 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Harpal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Prins Kumar | 06830016 | Physa Pharmaceuticals Private Limited | Director |
| Sumit Kumar | 09728525 | Physa Pharmaceuticals Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Harpal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Harpal
Harpal currently holds 1 directorship: Physa Pharmaceuticals Private Limited (Director, since 24 Jun 2022, revenue ₹70.7 Lakh (FY 2025)).
Harpal was first appointed on 26 Nov 2013 as Director at Webgallant Services Private Limited. The most recent appointment on record is 24 Jun 2022 at Physa Pharmaceuticals Private Limited.
Harpal held 1 earlier board appointment: Webgallant Services Private Limited (Director, 26 Nov 2013 to 10 Feb 2014).
The current boards of Harpal's companies include Prins Kumar (Physa Pharmaceuticals Private Limited), Sumit Kumar (Physa Pharmaceuticals Private Limited).